Pregnancy rate is greater when the corpus luteum is present during the period of progestin treatment to synchronize time of estrus in cows and heifers.
Our hypothesis was that conception in bovine females would be enhanced if the corpus luteum was present during the period of progestin treatment to synchronize estrus. In this study, 67 heifers (one replicate) and 124 cows (two replicates) were randomly assigned to one of two treatment groups. Seven days after estrus (Day 0), all animals were implanted with norgestomet and the implant remained in place for 10 days. All implants were removed on Day 17. Cows and heifers in one group received prostaglandin F2 alpha (PGF2 alpha) on Day 7 of the estrous cycle (PG 7; norgestomet without corpus luteum), and animals in the second group received PGF2 alpha on Day 17 (day of implant removal; PG 17; norgestomet with corpus luteum). All heifers and cows exhibiting behavioral estrus were artificially inseminated 12 h after estrus was detected during a 7-day period following removal of norgestomet. Blood samples were collected from cows of replicate 1 to determine serum concentrations of progesterone and 17 beta-estradiol. Percentage of females that had calves as a result of artificial insemination was greater (p < 0.01) in the PG 17 group (87% and 78% cows [two replicates] and 58% heifers) compared to the PG 7 group (31% and 44% cows [two replicates] and 41% heifers).(ABSTRACT TRUNCATED AT 250 WORDS)
Sanchez
T
T
Department of Animal Science, University of Nebraska-Lincoln 68583-0908.
Wehrman
M E
ME
Bergfeld
E G
EG
Peters
K E
KE
Kojima
F N
FN
Cupp
A S
AS
Mariscal
V
V
Kittok
R J
RJ
Rasby
R J
RJ
Kinder
J E
JE
D000818:Animals; D002417:Cattle; D003338:Corpus Luteum / Q000187:drug effects* / Q000502:physiology; D004958:Estradiol / Q000097:blood; D004973:Estrus Synchronization / Q000187:drug effects* / Q000502:physiology; D005260:Female; D005306:Fertilization / Q000187:drug effects* / Q000502:physiology; D007315:Insemination, Artificial / Q000662:veterinary; D006080:Ovarian Follicle / Q000187:drug effects / Q000254:growth & development / Q000502:physiology; D011247:Pregnancy; D011282:Pregnenediones / Q000494:pharmacology*; D045167:Progesterone Congeners / Q000494:pharmacology*; D013997:Time Factors
D011282:Pregnenediones; D045167:Progesterone Congeners; C100284:norgestomet; D004958:Estradiol